Implant
Opthalmology
Stanford
Paritosh Dubey
Date: October 22, 2025
Source: Stanford Medicine
News:
A Milestone in Restoring Functional Vision
The implant, named PRIMA and developed at Stanford Medicine, is the first prosthetic eye device to restore usable vision to individuals with otherwise untreatable vision loss. The technology enables patients to recognize shapes and patterns, a level of vision known as form vision.
"All previous attempts to provide vision with prosthetic devices resulted in basically light sensitivity, not really form vision," said Daniel Palanker, PhD, a professor of ophthalmology and a co-senior author of the paper. "We are the first to provide form vision."
The research was co-led by José-Alain Sahel, MD, professor of ophthalmology at the University of Pittsburgh School of Medicine, with Frank Holz, MD, of the University of Bonn in Germany, serving as lead author.
How the PRIMA System Works?
The system includes two main parts: a small camera attached to a pair of glasses and a wireless chip implanted in the retina. The camera captures visual information and projects it through infrared light to the implant, which converts it into electrical signals. These signals substitute for the damaged photoreceptors that normally detect light and send visual data to the brain.
The PRIMA project represents decades of scientific effort, involving numerous prototypes, animal testing, and an initial human trial.
Palanker first conceived the idea two decades ago while working with ophthalmic lasers to treat eye disorders. "I realized we should use the fact that the eye is transparent and deliver information by light," he said.
"The device we imagined in 2005 now works in patients remarkably well."
Replacing Lost Photoreceptors
Participants in the latest trial had an advanced stage of age-related macular degeneration known as geographic atrophy, which progressively destroys central vision. This condition affects over 5 million people worldwide and is the leading cause of irreversible blindness among older adults.
Discussion
0 CommentNo comments yet!